Han Steve, Chaya Craig, Hoo Guy W Soo
VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, Geffen School of Medicine at UCLA, Los Angeles, California 90073, USA.
J Intensive Care Med. 2006 Jul-Aug;21(4):240-5. doi: 10.1177/0885066606287047.
The objective was to describe and review the use of thrombolytic therapy in a patient with an intracranial tumor and massive pulmonary embolism. This is the first reported case of a patient with a known glioblastoma multiforme and massive pulmonary embolism who was successfully treated with alteplase. Pulmonary embolism was demonstrated by a ventilation-perfusion scan and transthoracic echocardiogram with repeat studies demonstrating resolution of the thromboembolism and reperfusion of pulmonary vasculature. A review of the literature revealed that the incidence of intracranial hemorrhage with thrombolysis is <3% and compares favorably with the much higher mortality rate of 25% to >/=50% in patients with hemodynamically unstable pulmonary emboli. The benefit of thrombolysis may outweigh the risks of intracranial hemorrhage in these patients, and careful consideration for its use in these patients is warranted.
目的是描述和回顾在一名患有颅内肿瘤和大面积肺栓塞的患者中使用溶栓治疗的情况。这是首例已知多形性胶质母细胞瘤并伴有大面积肺栓塞的患者成功接受阿替普酶治疗的报告病例。通气-灌注扫描和经胸超声心动图证实了肺栓塞,重复检查显示血栓栓塞消退且肺血管再灌注。文献回顾显示,溶栓治疗导致颅内出血的发生率<3%,与血流动力学不稳定的肺栓塞患者25%至≥50%的高得多的死亡率相比更具优势。在这些患者中,溶栓的益处可能超过颅内出血的风险,因此有必要仔细考虑在这些患者中使用溶栓治疗。